GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Caution] not approved anywhere. keep posts descriptive. — 23 comments in the full submission. View in context.
522
c/cagrilintide·submitted 22 days ago by u/pancreatitis_scare

[Caution] not approved anywhere. keep posts descriptive.

Cautionbranch of 6 comments

not approved anywhere. keep posts descriptive. Not a hot take, just something I have not seen said plainly here. Sent a vial to Medutest because there was almost nothing on file for this compound. 98.1% against a claimed 97.5%, and I posted it because the log needs entries. Combination and monotherapy arms must be…

Read the full submission and all 23 comments →

This branch

6 comments, started 21 days ago
u/noor_ivaturi15 points·21 days ago

do not assume the dosing intuitions from the GLP-1 boards transfer

replysharereportpermalink
u/pancreatitis_scareOP8 points·21 days ago

How many separate lots has anyone here tested?

replysharereportpermalink
u/lipid_panel_larrybloodwork9 points·21 days ago

do not assume the dosing intuitions from the GLP-1 boards transfer

This is the distinction that keeps this board honest — different axis, not a stronger version of the same one.

replysharereportpermalink
u/erez_perrin5 points·21 days ago

That result is preclinical. Worth flagging, since the thread has been reading it as human data.

replysharereportpermalink
u/pancreatitis_scareOP9 points·21 days ago

satiety signalling rather than incretin signalling

replysharereportpermalink
u/pavel_halvorsen4 points·21 days ago

Same view — long-acting is the engineering achievement here, and it is why the molecule exists at all.

replysharereportpermalink

← back to the whole thread

About c/cagrilintide

Amylin analog pharmacology and the CagriSema combination: why amylin and GLP-1 co-agonism produces a different satiety profile, the REDEFINE readouts, and the very limited pool of people handling cagrilintide as research material.

19kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/cagrilintide
c/cagrilintide rules
  1. Amylin is not a GLP-1. Posts conflating them get corrected.
  2. CagriSema ratios in trials are fixed-dose. Do not extrapolate to self-mixing.
  3. Not approved anywhere. Keep posts descriptive, not instructional.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/amylin_amyu/incretin_ivyu/ledger_mod
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →